Follow-up of COVID-19 Vaccine Response in Strasbourg University Hospitals

Launched by UNIVERSITY HOSPITAL, STRASBOURG, FRANCE · Apr 19, 2021

Keywords

ClinConnect Summary

This clinical trial is looking into how well COVID-19 vaccines work by measuring the antibodies people have after being vaccinated. Antibodies are proteins that help fight off infections. Researchers want to find out if there are differences in vaccine responses based on factors like age and gender, since previous studies suggest this might be the case. With vaccines showing effectiveness rates between 62% and 95%, understanding these responses can help improve vaccination strategies.

If you're over 18 and have received a COVID-19 vaccine along with a blood test to check for antibodies, you might be eligible to participate. Participation involves giving consent for your blood samples and any related data to be stored and used for research. During the trial, you can expect to share some basic information, and your health will be monitored to help researchers learn more about how different factors affect vaccine responses. It's important to know that people who cannot clearly communicate or are under certain legal protections cannot take part in this study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • - Any person, male or female, over 18 years of age who underwent vaccination and
• • anti-SARS-CoV-2 serological test after vaccination
• * having already given their consent for their biological resources to be:
• • stored in a biocollection of the Microbiology Technical Platform (PTM) having received an approval from the CPP Est-IV and declared to the Ministry of Education and Research under reference No. DC2009-1002;
• • subsequently reused, as well as the anonymized associated data, for research purposes
• Exclusion Criteria:
• • Inability to give clear information (person in an emergency, difficulty understanding the subject, etc.)
• • Person under safeguard of justice
• • Person under guardianship or curatorship-